TAZAROTENE

Cosette Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 29, 2023
Approval ID: ecd718fd-c06e-4b3a-8aca-fa51e7c51a66
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05%, for topical use Initial U.S. Approval: 1997

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.